iTEC as a new experimental system for TEC biology
iTEC 作为 TEC 生物学的新实验系统
基本信息
- 批准号:10493405
- 负责人:
- 金额:$ 18.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-22 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptionAutologousBiologyCell CycleCell Differentiation processCell ProliferationCell physiologyCellsCellular biologyCoculture TechniquesComplexCoupledDown-RegulationEmbryoEndodermEpithelialEpithelial Cell ProliferationFibroblastsFutureGenerationsGeneticGoalsIn VitroMHC Class II GenesMaintenanceMethodsModificationMolecularMusOrganOrgan SizeOrganogenesisPathway interactionsProcessProtocols documentationRoleSignal TransductionSystemT cell differentiationT-Cell DevelopmentT-LymphocyteTestingTherapeuticThymic epithelial cellThymus GlandTransplantationUp-RegulationWorkadaptive immune responseage relatedcell typedesigndirected differentiationdosageepithelial stem cellexperimental studyfetalimprovedin vivoinduced pluripotent stem cellnotch proteinnovelorganoid transplantationoverexpressionpostnatalprogramsresponsesingle-cell RNA sequencingstem cellsthymocytetooltranscription factortwo-dimensional
项目摘要
Project Summary/Abstract
The thymus is the key organ required for T cell generation and the formation of an adaptive immune response.
One key cell type, endoderm-derived thymic epithelium, is required both for all thymus functions and to
orchestrate the assembly and differentiation of all other cell types within the thymus. The genetic pathways
underlying the specification and differentiation of these thymic epithelial cells (TECs) are still poorly understood.
However, a single transcription factor, FOXN1, is known to control multiple key aspects of TEC proliferation,
differentiation, and maintenance in both the fetal and postnatal thymus. Work from our lab and others has shown
that Foxn1 acts differentially in TEC subsets and is incredibly dosage-sensitive, and that its expression in TEC
progenitors is sufficient to drive most if not all of the TEC differentiation program. Because of this central role,
Foxn1 is a key target in ongoing efforts to generate TEC by the directed differentiation of induced pluripotent
stem cells (iPSCs). However, many questions remain about the precise FOXN1 functions in TEC differentiation
and proliferation. While at least some of the FOXN1 targets required for TEC function are known, key questions
remain unanswered, including the molecular pathways that establish TEC identity and initiate Foxn1 expression,
and how diverse levels of FOXN1 in different TEC subsets differentially control TEC biology. We were part of a
collaborative team that showed that enforced expression of FOXN1 in murine embryonic fibroblasts (MEFs) is
sufficient to convert MEFs into functional TEC. These “induced TECs” (iTECs) can, upon transplantation, direct
the assembly of a fully functional thymus organ that supports development of T cells in vivo. iTECs also show
promise in promoting differentiation of immature thymocytes into single positive T cells in 2-dimensional culture.
iTECs may thus provide a novel tool for long-term goals of generating autologous TEC in vitro that could be used
to generate organoids for transplant, or for in vitro generation of T cells for therapeutic purposes. More broadly,
the field of thymus biology lacks a viable in vitro culture system for studying the molecular requirements for TEC
biology and differentiation, or TEC-thymocyte interactions that direct T cell development and selection. iTECs
thus could provide a useful in vitro system for studying both FOXN1 function and the genetic pathways that
control TEC differentiation and function. This proposal is designed to address key aspects of iTEC generation
that limit its broader adoption as an experimental system. We propose three specific aims focused on improving
the control of iTEC differentiation and proliferation that will allow us to develop this method for broad experimental
applications: 1) Foxn1 dosage sensitivity during iTEC generation; 2) mechanisms to promote mTEC
differentiation in iTEC cultures; and 3) MHCII expression and iTEC proliferation. Successful completion of the
proposed experiments will substantially improve iTEC generation and function, with the goal of establishing
iTECs as into a much-needed in vitro experimental system with broad utility for studying FOXN1 function and
TEC biology, T cell differentiation, and TEC-thymocyte interactions.
项目摘要/摘要
胸腺是T细胞产生所需的关键器官,并且是自适应免疫响应的形成。
所有胸腺功能都需要一种关键的细胞类型,内胚层衍生的胸腺上皮,既需要
策划胸腺内所有其他细胞类型的组装和分化。遗传途径
这些胸腺上皮细胞(TEC)的规范和分化的基础仍然很少了解。
但是,已知一个单个转录因子FOXN1控制TEC增殖的多个关键方面,
胎儿和产后胸腺的分化和维持。我们实验室和其他人的工作表明
FOXN1在TEC子集中有不同的作用,并且对剂量敏感,并且其表达在TEC中
祖细胞足以推动大多数TEC分化计划(如果不是全部)。由于这种核心角色,
FOXN1是通过诱导多能的指示分化来生成TEC的持续努力的关键目标
干细胞(IPSC)。但是,关于TEC差异化的精确FOXN1功能仍然存在许多问题
和增殖。虽然至少已经知道了一些FOXN1目标,但关键问题
保持未得到答复,包括建立TEC身份并启动FOXN1表达的分子途径,
以及不同TEC子集中FOXN1水平的多样化对TEC生物学的控制。我们是一个
协作团队表明,在鼠类胚胎成纤维细胞(MEFS)中强制执行FOXN1的表达是
足以将MEF转换为功能性TEC。这些“诱导的TEC”(ITEC)可以直接直接
支持体内T细胞发育的功能性胸腺器官的组装。 ITEC也显示
在二维培养中促进未成熟胸腺细胞分化为单个阳性T细胞的有望。
因此,ITEC可以为在体外生成自体TEC的长期目标提供新颖的工具,可以使用
生成用于移植的器官,或用于治疗目的的体外产生T细胞。更广泛地
胸腺生物学领域缺乏可行的体外培养系统,用于研究TEC的分子需求
生物学和分化,或指向T细胞发育和选择的TEC-胞胞菌相互作用。 itecs
因此,可以为研究FOXN1功能和遗传途径提供有用的体外系统
控制TEC分化和功能。该建议旨在解决ITEC生成的关键方面
这限制了其作为实验系统的广泛采用。我们提出了三个专注于改进的特定目标
ITEC分化和增殖的控制,这将使我们能够开发此方法进行广泛的实验
应用:1)ITEC生成期间FOXN1剂量敏感性; 2)促进MTEC的机制
ITEC文化的分化; 3)MHCII表达和ITEC增殖。成功完成
提出的实验将大大改善ITEC的生成和功能,目的是建立
ITEC作为一个急需的体外实验系统,具有广泛的实用性,用于研究FOXN1功能和
TEC生物学,T细胞分化和TEC-胞胞菌相互作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nancy R Manley其他文献
Foxn1 is required for thymic vascularization
Foxn1 是胸腺血管形成所必需的
- DOI:
- 发表时间:
2009 - 期刊:
- 影响因子:0
- 作者:
Takuya Saiki;Kei Mukohara Takashi Otani;Nobutaro Ban.;T.Kaisho;改正恒康;Nancy R Manley - 通讯作者:
Nancy R Manley
CASA: A new method for quantifying organization
CASA:一种量化组织的新方法
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
Kawakami M;Morita S;Sunohara M;Amano Y;Ishikawa R;Watanabe K;Hamano E;Ohishi N;Nakajima J;Yatomi Y;Nagase T;Fukayama M;Takai D.;井手均,岩瀬正典,中村宇大,藤井裕樹,大隈俊明,城臺環,筒信隆,布井清秀,五島大祐,野原栄,篠原規恭,南昌江,和田美也,横溝由史,菊池正統,野見山理久,中村晋,田代憲司,吉成元孝,北園孝成;Nancy R Manley - 通讯作者:
Nancy R Manley
Foxnl is required for thymic vascularization
Foxnl 是胸腺血管化所必需的
- DOI:
- 发表时间:
2009 - 期刊:
- 影响因子:0
- 作者:
Iwasaki;Y.;et al.;高浜洋介;織田順;善本知広;改正恒康;赤松園子・服部淳子・西原みゆき・山口佳子・岡崎章;Nancy R Manley - 通讯作者:
Nancy R Manley
Nancy R Manley的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nancy R Manley', 18)}}的其他基金
iTEC as a new experimental system for TEC biology
iTEC 作为 TEC 生物学的新实验系统
- 批准号:
10373479 - 财政年份:2021
- 资助金额:
$ 18.88万 - 项目类别:
Project 2 - The role of Foxn1 in controlling the transition from thymus expansion to homeostasis
项目 2 - Foxn1 在控制胸腺扩张到稳态转变中的作用
- 批准号:
10022938 - 财政年份:2020
- 资助金额:
$ 18.88万 - 项目类别:
Project 2 - The role of Foxn1 in controlling the transition from thymus expansion to homeostasis
项目 2 - Foxn1 在控制胸腺扩张到稳态转变中的作用
- 批准号:
10251298 - 财政年份:2020
- 资助金额:
$ 18.88万 - 项目类别:
Identifying new genes involved in thymic involution
鉴定参与胸腺退化的新基因
- 批准号:
9909275 - 财政年份:2020
- 资助金额:
$ 18.88万 - 项目类别:
Identifying new genes involved in thymic involution
鉴定参与胸腺退化的新基因
- 批准号:
10092939 - 财政年份:2020
- 资助金额:
$ 18.88万 - 项目类别:
Project 2 - The role of Foxn1 in controlling the transition from thymus expansion to homeostasis
项目 2 - Foxn1 在控制胸腺扩张到稳态转变中的作用
- 批准号:
10689296 - 财政年份:2020
- 资助金额:
$ 18.88万 - 项目类别:
Project 2 - The role of Foxn1 in controlling the transition from thymus expansion to homeostasis
项目 2 - Foxn1 在控制胸腺扩张到稳态转变中的作用
- 批准号:
10470931 - 财政年份:2020
- 资助金额:
$ 18.88万 - 项目类别:
Project 1: Thymic and peripheral Aspects of T cell Aging and Rejuvenation
项目 1:T 细胞衰老和再生的胸腺和外周方面
- 批准号:
10226921 - 财政年份:2017
- 资助金额:
$ 18.88万 - 项目类别:
Mouse models for TB infection across the lifespan
整个生命周期的结核感染小鼠模型
- 批准号:
8772193 - 财政年份:2014
- 资助金额:
$ 18.88万 - 项目类别:
Molecular mechanisms and epigenetic signatures that specify thymus fate
决定胸腺命运的分子机制和表观遗传特征
- 批准号:
9436424 - 财政年份:2014
- 资助金额:
$ 18.88万 - 项目类别:
相似国自然基金
采用新型视觉-电刺激配对范式长期、特异性改变成年期动物视觉系统功能可塑性
- 批准号:32371047
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
破解老年人数字鸿沟:老年人采用数字技术的决策过程、客观障碍和应对策略
- 批准号:72303205
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
通过抑制流体运动和采用双能谱方法来改进烧蚀速率测量的研究
- 批准号:12305261
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
采用多种稀疏自注意力机制的Transformer隧道衬砌裂缝检测方法研究
- 批准号:62301339
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
政策激励、信息传递与农户屋顶光伏技术采用提升机制研究
- 批准号:72304103
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Allogeneic BAFF Ligand Based CAR T Cells as a Novel Therapy for B Cell Malignancies
基于同种异体 BAFF 配体的 CAR T 细胞作为 B 细胞恶性肿瘤的新疗法
- 批准号:
10698759 - 财政年份:2023
- 资助金额:
$ 18.88万 - 项目类别:
Deciphering unintended large gene modifications in gene editing for sickle cell disease
破译镰状细胞病基因编辑中意外的大基因修饰
- 批准号:
10720685 - 财政年份:2023
- 资助金额:
$ 18.88万 - 项目类别:
Graft harvest as a model of tendon injury; Trajectory of recovery and clinical outcomes
移植物收获作为肌腱损伤的模型;
- 批准号:
10672279 - 财政年份:2022
- 资助金额:
$ 18.88万 - 项目类别:
Graft harvest as a model of tendon injury; Trajectory of recovery and clinical outcomes
移植物收获作为肌腱损伤的模型;
- 批准号:
10417618 - 财政年份:2022
- 资助金额:
$ 18.88万 - 项目类别:
Discovery and development of potent inhibitors of Jun N-terminal kinase for non-hormonal treatment of endometriosis and associated pain
发现和开发 Jun N 末端激酶的有效抑制剂,用于子宫内膜异位症和相关疼痛的非激素治疗
- 批准号:
10467991 - 财政年份:2021
- 资助金额:
$ 18.88万 - 项目类别: